logo

BridgeBio Pharma Inc (BBIO) Stock: Navigating Market Highs and Lows in 52 Weeks

VIPS stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. BridgeBio Pharma Inc’s current trading price is -47.20% away from its 52-week high, while its distance from the 52-week low is 52.44%. The stock’s price range for this period has been between $15.35 and $44.32 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 7.86 million for the day, a number notably higher than the average daily volume of 1.61 million over the last three months.

BridgeBio Pharma Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $44.32 on 12/28/23, while the lowest price for the same duration was marked at $15.35 on 06/26/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

BridgeBio Pharma Inc (BBIO) has experienced a quarterly decline of -20.89% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.38B and boasts a workforce of 550 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 29.44, with a change in price of -13.01. Similarly, BridgeBio Pharma Inc recorded 1,739,546 in trading volume during the last 100 days, posting a change of -36.05%.

BBIO Stock Stochastic Average

As of today, BridgeBio Pharma Inc’s raw stochastic average for the last 50 days stands at 14.88%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 14.88%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 17.45% and 20.57%, respectively.

BBIO Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -42.04% this year. Over the last six months, there has been a stronger performance of -38.74%. The price of BBIO leaped by -20.05% during the last 30 days period. For the last 5-days stocks have slided -16.01%.

Most Popular